STOCK TITAN

PTC Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Rhea-AI Summary

PTC Therapeutics announced its participation in the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021, at 7:30 a.m. EST. The event will be webcast live, with a replay available for 30 days. The company focuses on developing and commercializing innovative medicines for rare disorders, aiming to improve patient access to necessary treatments. Interested parties are encouraged to join the webcast via the investor relations section on PTC's website.

Loading...
Loading translation...
Argus Session date unavailable
-0.87% session move Open Argus
Details

News Market Reaction – PTCT

The recorded move for PTCT in the trading session of this news was -0.87%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SOUTH PLAINFIELD, N.J., Jan. 4, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company update at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11th at 7:30 a.m. EST.

The presentation will be webcast live on the Events and Presentations page under the investor relations section of PTC Therapeutics' website at www.ptcbio.com and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.

About PTC Therapeutics, Inc.
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.

FOR MORE INFORMATION PLEASE CONTACT:
Media & Investors:    
Jane Baj  
+1 (908) 912-9167 
jbaj@ptcbio.com  

Cision View original content:http://www.prnewswire.com/news-releases/ptc-therapeutics-to-present-at-the-39th-annual-jp-morgan-healthcare-conference-301198727.html

SOURCE PTC Therapeutics, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will PTC Therapeutics present at the J.P. Morgan Healthcare Conference?

PTC Therapeutics will present on January 11, 2021, at 7:30 a.m. EST.

How can I watch the PTC Therapeutics presentation at the conference?

The presentation will be webcast live on PTC's website and archived for 30 days.

What is the focus of PTC Therapeutics?

PTC Therapeutics specializes in developing medicines for patients with rare disorders.

Where can I find more information about PTC Therapeutics?

More information can be found on PTC Therapeutics' website at www.ptcbio.com.

Keep reading